How Multivitamins Are Made

A multivitamin is not a single ingredient — it is a finished dosage form assembled from dozens of individually sourced compounds, each with its own chemical behavior, stability profile, and regulatory requirement. The manufacturing process must reconcile all of those differences before a tablet, capsule, or softgel reaches a retail shelf.

This piece covers the sequence of steps a contract or in-house manufacturer follows when producing a multivitamin: how raw materials are sourced and tested, how they are blended and formed, and how fat-soluble and water-soluble vitamins are handled differently because their absorption in the body depends on fundamentally different chemistry.

The Manufacturing Sequence: From Raw Ingredients to Finished Form

Multivitamin production begins at the raw-material stage. Each vitamin and mineral arrives at the manufacturing facility as a purified compound — retinyl palmitate for vitamin A, cholecalciferol for vitamin D3, ascorbic acid for vitamin C, and so on. Minerals typically arrive as salts: magnesium oxide, zinc gluconate, calcium carbonate. Before any blending begins, incoming materials are quarantined and tested for identity, purity, potency, and the absence of contaminants such as heavy metals and microbes.

Once released by quality control, ingredients move into a pre-blend or granulation step. Because many vitamins and minerals are present in milligram or microgram quantities, they cannot simply be scooped into a mixer alongside bulking agents — the mass difference is too great for uniform distribution. Manufacturers address this through geometric dilution, a method in which a small quantity of active ingredient is mixed first with an equal volume of excipient, then the resulting blend is mixed with another equal volume, and so on until the active is uniformly distributed throughout the full batch.

Granulation follows for many formulas. Wet granulation binds powders with a liquid binder, then dries and mills them into granules of consistent size and flow. Dry granulation (roller compaction) achieves a similar result without liquid, which matters for moisture-sensitive nutrients like certain B vitamins. Granulation improves flowability through equipment hoppers and ensures that each tablet or capsule receives a consistent portion of every ingredient.

For tablets, the granulated blend is fed into a rotary tablet press, where metal punches compress the powder under several tons of force per punch. Coating follows: a film coat seals the tablet against moisture and oxygen, masks bitter flavors, and — in the case of enteric coatings — delays dissolution until the tablet passes the stomach. Capsules are filled on separate equipment that meters the blend into hard-shell gelatin or vegetable (HPMC) capsules. Softgels, commonly used for fat-soluble vitamins, are formed by encasing an oil-based fill material inside a plasticized gelatin shell in a continuous rotary die process.

After forming, finished units are inspected for weight uniformity, disintegration time, and physical defects. Samples from each batch are retained and tested against finished-product specifications before the batch is released for packaging.

Ingredients, Excipients, and the Organs That Process the Result

Fat-soluble vitamins (A, D, E, K). These compounds are lipophilic — they dissolve in fat, not water. In manufacturing, they are typically pre-dispersed in a carrier oil or spray-dried onto a starch matrix to make them blendable with dry ingredients. Fat-soluble vitamins are absorbed with dietary fat in the small intestine: bile salts emulsify fat into micelles, and the vitamins are incorporated into those micelles before crossing the intestinal wall. Because absorption depends on fat co-ingestion, the physical form in which these vitamins appear in a finished product — oil-filled softgel versus dry powder tablet — can influence how completely they are absorbed. A detailed account of that process appears in the article on how fat-soluble vitamins are absorbed.

Water-soluble vitamins (B-complex, C). These dissolve readily in aqueous environments and do not require lipid carriers. They are absorbed primarily in the small intestine via specific transporter proteins. Because they are not stored in fat tissue to the same degree as fat-soluble vitamins, the body excretes excess amounts in urine relatively quickly. In manufacturing, some water-soluble vitamins — riboflavin and B12 in particular — require protection from light and heat during processing.

Minerals. Minerals arrive as salts whose elemental content varies by compound. Magnesium oxide contains a higher percentage of elemental magnesium by weight than magnesium citrate, but the two forms differ in solubility and therefore in how readily the gut can absorb the magnesium ion. Manufacturers choose mineral forms based on elemental yield, cost, solubility, and compatibility with other ingredients in the blend.

Excipients. These are inactive ingredients — binders, disintegrants, lubricants, flow agents, and coating polymers — that have no nutritional function but are essential to the manufacturing process. Microcrystalline cellulose binds tablets; croscarmellose sodium helps them break apart in the gut; magnesium stearate lubricates the punch faces of a tablet press. The identity and quantity of excipients must be disclosed to the FDA in manufacturing records, though they appear on consumer labels only as a collective "other ingredients" list.

The gastrointestinal tract. The stomach's acidic environment begins dissolving uncoated tablets and activating some mineral salts. The small intestine — particularly the duodenum and jejunum — is the primary site of vitamin and mineral absorption. The liver processes absorbed fat-soluble vitamins before they enter systemic circulation, and the kidneys filter excess water-soluble vitamins into urine.

Where the Process Breaks Down or Produces Unexpected Results

Ingredient incompatibility. Certain minerals catalyze the oxidation of vitamins when they share a tablet matrix. Iron and copper, for example, can degrade vitamin C and some B vitamins over the shelf life of the product. Manufacturers attempt to separate reactive ingredients through layered tablet designs or by placing them in separate compartments, but complete separation is difficult in a single-unit dosage form.

Compression damage. High compression forces during tableting can reduce the bioavailability of some nutrients by creating a matrix so dense that stomach acid and digestive enzymes cannot penetrate it within the time the tablet spends in the gut. A tablet that passes a dissolution test in a laboratory bath at 37°C does not always behave identically in a living gastrointestinal tract, where transit time, pH, and enzymatic activity vary between individuals.

Overage and degradation. Because potency declines over a product's shelf life — especially for vitamins C, B1, and folic acid — manufacturers routinely add an overage: a percentage above the labeled amount intended to ensure the product still meets its stated potency at the expiration date. The size of that overage is not required to appear on the label, meaning a product may contain meaningfully more of a nutrient at the time of manufacture than is printed on the Supplement Facts panel.

Fat-soluble vitamin absorption variability. Because fat-soluble vitamins are absorbed with dietary fat, a multivitamin consumed without any fat in the meal produces lower absorption of vitamins A, D, E, and K than the same product taken with a fat-containing meal. This is a physiological variable, not a manufacturing defect, but it means that the labeled amount of a fat-soluble vitamin does not translate into a fixed absorbed amount across all consumption contexts.

Blending uniformity failures. Despite geometric dilution and granulation, blend uniformity can fail at scale. If the granulation step is incomplete, some tablets in a batch may contain a higher concentration of a micronutrient than others. This is one reason FDA's current Good Manufacturing Practice (cGMP) regulations require manufacturers to test finished units for content uniformity rather than relying solely on the blend test.

What a Multivitamin Label Shows — and What It Does Not

The Supplement Facts panel on a multivitamin lists each nutrient, its quantity per serving, and — where an established value exists — the percentage of the Daily Value (%DV) that quantity represents. Daily Values are reference amounts set by the FDA and used for labeling purposes; they are not individualized recommendations.

What the label does not show is the chemical form of each nutrient. A label may read "Vitamin B12 … 100 mcg" without specifying whether that B12 is cyanocobalamin, methylcobalamin, or adenosylcobalamin — forms that differ in their metabolic handling. Similarly, "Magnesium … 100 mg" does not indicate whether the source is magnesium oxide, citrate, glycinate, or another salt, each of which has a different solubility profile.

Third-party certification marks — from organizations that verify identity, potency, and manufacturing cleanliness — indicate that an independent laboratory tested the product against its label claims. Such a seal is not FDA approval. No dietary supplement is FDA-approved before it reaches the market. The FDA operates a post-market surveillance system; it can take action against a product after it is already on sale if evidence of adulteration, misbranding, or safety concerns emerges. The mechanics of that process are described in the article on what actually happens during a supplement recall.

A certificate of analysis (COA) from the manufacturer or a third-party laboratory provides batch-specific test data — potency, heavy metals, microbial counts — but COAs are not routinely available to consumers at retail and are not required to be displayed on the label. The label's expiration date signals the period during which the manufacturer asserts the product meets its labeled potency, assuming it has been stored under the conditions stated on the packaging.

Multivitamin manufacturing is a convergence of pharmaceutical-style processing and dietary supplement regulation — a field where dozens of chemically distinct compounds must coexist stably in a single small tablet, and where the gap between what a label states and what the body ultimately absorbs is shaped by formulation choices, excipient selection, and the basic physiology of the gastrointestinal tract.

Note: This explains how supplements work. This statement has not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for advice from a physician, pharmacist, or registered dietitian.